| 
				
			 | 
			
					
						
							
								
									  | 
									 | 
								 
								
									| Home > Product > Product Information    | 
								 
								
									 | 
								 
								
									 | 
								 
							 
						 | 
					 
					
					
						
									
										
											
												   DQuvan Tab. | 
											 
											
												 | 
											 
											
												
												
												| 
												
													
													
												 | 
												
												
												
													
													
												 | 
												
												
												
													
													
												 | 
												
												
												
													
													
												 | 
												
													
												
												 | 
												
													
														
															 | 
														 
														
															 | 
														 
														
															  | 
															 | 
															 | 
														 
														
															 | 
														 
														
															  | 
															 | 
															[Essential hypertension, heart failure, reduced risk of death after myocardial infarction | 
														 
														
															 | 
														 
														
															  | 
															 | 
															Valsartan | 
														 
														
															 | 
														 
														
															  | 
															 | 
															80 milligrams: pale pink, convex circular film coated tablet | 
														 
														
															 | 
														 
														
															  | 
															 | 
															Ethical the Counter(ETC) | 
														 
														
															 | 
														 
														
															  | 
															 | 
															 | 
														 
														
															 | 
														 
														
															  | 
															 | 
															 | 
														 
														
															 | 
														 
														
															 | 
														 
													 
												 | 
											 
											
												 | 
											 
											
												| 
													
												 | 
											 
											
												 | 
											 
											
												| 
													
												 | 
											 
											
												 | 
											 
											
												
														
															[Precautions for use]
  1. Do not administer to the following patients 1) Patients who are hypersensitive to the components of this drug 2) Pregnant women 3) Patients with severe renal impairment (creatinine clearance <10 mL / min) (no experience) 4) Severe hepatic impairment, cirrhosis or biliary obstruction | 
														 
													
  | 
														 
													  | 
											 
											
												 | 
											 
											
												  | 
											 
	 
						 | 
					 
				 
 |